Skip to main navigation Skip to search Skip to main content

An Open-Label, Multicenter Study to Assess Disease Activity and Biomarkers of Neuronal Damage in Minority Patients with Relapsing Multiple Sclerosis Receiving Treatment with Ocrelizumab

    Project: Research

    Project Details

    StatusActive
    Effective start/end date09/1/20 → …